Although nanoparticles are extensively used in a wide range of commercial applications, the understanding of their toxicity has started to emerge only recently and confusion regarding their safe use is widespread. In this project, we aim to assess the toxicity of newly-invented nanoparticles which have applications in biomedical materials such as drug delivery. Consequences of exposure to the nanoparticles will be assessed (using appropriate ISO standard protocols) by effects on viability, proliferation and cytokine release. One outcome of this project will be known toxicity and drug delivering ability of new nanoparticles.
|Effective start/end date||5/09/11 → 1/06/12|